Table 2. Key performance indicators summarized at various ecological levels.
| MEASURE | INDICATORS | Individual | Interpersonal | Village |
|---|---|---|---|---|
| 1. Fidelity – Dose | 1.1 Number of participatory learning acitivity sessions | X | ||
| 1.2 Number of media demonstrations | X | |||
| 1.3 Number of women participating in Hemoglobin
testing |
X | X | X | |
| 1.4 Number of community engagement meetings | X | X | ||
| 1.5 Number of hemoglobin testing demonstrations | X | X | X | |
| 1.6 Number of women tested as anemic (mild,
moderate, or severe) |
X | X | ||
| 1.7 Number of referrals to community clinical linkages
for anemic women |
X | X | ||
| 1.8 % of self-reported iron folic acid supplementation
intake status (currently taking, previously taken, or never taken) |
X | X | ||
| 2. Quality – Reach | 2.1 Number of women of reproductive age reached | X | ||
| 2.2 Number of adolescent girls reached | X | |||
| 2.3 Number of mothers-in-law reached | X | |||
| 2.4 Number of pregnant women reached | X | |||
| 2.5 Number of frontline workers reached | X | |||
| 2.6 Number of policy workers reached | X | |||
| 2.7 Number of men reached | X | |||
| 3.1 CF performance | X | X | ||
| 3.2 Qualitative barriers, facilitators, challenges, or
opportunities |
X | X | X | |
| 3.3 Unintended consequences (neutral, positive or
negative) |
X | X | X | |
| 4. Receptivity
– Reactions |
4.1 Number of thumbs up for comm products | X | ||
| 4.2 Number of thumbs down for products | X | |||
| 4.3 Number of thumbs up for participatory learning
acitivitysessions |
X | |||
| 4.4 Number of thumbs down for participatory learning
acitivity sessions |
X | |||
| 4.5 Number of attendees willing to return to
participatory learning acitivity sessions and community engagement meetings |
X | |||
| 4.6 Number of returning attendees for participatory
learning acitivity sessions and community engagement meetings |
X | |||
| 4.7 Qualitative barriers, facilitators, challenges, or
opportunities |
X | X | X | |
| 4.8 Unintended consequences (neutral, positive or
negative) |
X | X | X | |
| 5. Iron Folic Acid
– Supply and Demand |
5.1 Number of iron folic acid supply points with readily
available stock |
X | ||
| 5.2 Number of iron folic acid supply points with IFA in
short supply |
X | |||
| 5.3 Number of iron folic acid supply points with IFA
stock-outs |
X | |||
| 5.4 Number of iron folic acid supply points reporting
an increase in demand |
X | |||
| 5.5 Qualitative barriers, facilitators, challenges, or
opportunities |
X | X | X | |
| 5.6 Unintended consequences (neutral, positive or
negative) |
X | X | X |